Ephedrine Alkaloid AERs Nearly Double Over Two Years - AAPCC Data
This article was originally published in The Tan Sheet
Executive Summary
Adverse event reports related to ephedrine alkaloid dietary supplement use almost doubled between 1997 and 1999, according to poison control center data cited in a Sept. 5 citizen petition to FDA.
You may also be interested in...
Ephedra Safety Risk Evidence Sufficient For Market Ban – Rep. Waxman
There is currently enough evidence of risk to remove ephedra from the market, Rep. Henry Waxman (D-Calif.) maintained at the Food & Drug Law Institute's Annual Educational Conference in Washington, D.C. April 1
Ephedra Safety Risk Evidence Sufficient For Market Ban – Rep. Waxman
There is currently enough evidence of risk to remove ephedra from the market, Rep. Henry Waxman (D-Calif.) maintained at the Food & Drug Law Institute's Annual Educational Conference in Washington, D.C. April 1
Ephedra Safety Risk Evidence Sufficient For Market Ban – Rep. Waxman
There is currently enough evidence of risk to remove ephedra from the market, Rep. Henry Waxman (D-Calif.) maintained at the Food & Drug Law Institute's Annual Educational Conference in Washington, D.C. April 1